<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        6-288-03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PANADOL ACTIFAST FILM COATED TABLETE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PARACETAMOL,SODIUM BICARBONATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500,173
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        9.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXOSMITHKLINE (GSK)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXOSMITHKLINE (GSK)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXOSMITHKLINE (GSK)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02BE51
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.8pt; margin-right:4.65pt">Panadol Actifast is an analgesic and antipyretic. It is recommended in the short-term management of mild pain such as headaches,<br />musculoskeletal pain, menstrual pain, toothache and for relieving fever, aches and pains of common colds and flu.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.8pt; margin-right:26.8pt"><strong>Before you take Panadol Actifast<br />a. Do not take Panadol Actifast in case of:</strong><br />- Known or previous history of hypersensitivity to paracetamol or any other ingredients.<br /><strong>b. Take special care with Panadol Actifast:</strong><br />- This product contains Paracetamol. Do not use with any other paracetamolcontaining products. The concomitant use with other products containing paracetamol may lead to an overdose. Paracetamol overdose may cause liver<br />failure which can lead to liver transplant or death.<br />- Cases of hepatic dysfunction/failure have been reported in patients with depleted<br />glutathione levels, such as those who are severely malnourished, anorexic, have a low body mass index or are chronic heavy users of alcohol.<br />- Caution in patients with glutathione depleted states such as sepsis; the use of<strong> </strong>paracetamol may increase the risk of metabolic acidosis.<br />- This medicinal product contains 352 mg of sodium per dose, equivalent to 17.6% of the WHO recommended maximum daily intake for sodium. The maximum daily dose of this product is equivalent to 70.4% of the WHO recommended maximum daily intake for sodium. Panadol Actifast is<br />considered high in sodium. This should be particularly taken into account for those on a low salt diet.<br />- Underlying liver disease increases the risk of paracetamol-related liver damage. Patients who have been diagnosed with liver or kidney impairment must seek medical advice before taking this medication.<br />- If symptoms persist, seek medical advice.</p><p style="margin-left:6.8pt; margin-right:26.8pt">Prolonged use except under medicalsupervision may be harmful.<br />- Keep out of sight and reach of children.</p><p style="margin-left:6.8pt; margin-right:26.8pt"><strong>c. Taking other medicines:</strong><br />The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by cholestyramine. The<br />anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol with increased risk of bleeding; occasional doses have no significant effect.</p><p style="margin-left:6.8pt; margin-right:26.8pt"><strong>d. Pregnancy &amp; breast feeding:</strong><br />- A large amount of data on pregnant women indicate neither malformative, nor feto/neonatal toxicity. Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically needed, paracetamol can be used during pregnancy however it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency.<br />- Paracetamol is excreted in breast milk. However, the level of paracetamolpresent is not considered to be harmful.<br />Available published data do notcontraindicate breastfeeding.</p><p style="margin-left:6.8pt; margin-right:26.8pt"><strong>e. Ability to perform tasks that require</strong><br />judgment, motor or cognitive skills:<br />- No significant effect on ability to drive or use machines.</p><p style="margin-left:6.8pt; margin-right:26.8pt">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.8pt; margin-right:4.65pt">- For oral administration only.<br />- Do not exceed the stated dose.<br />- Should not be used with other paracetamol-containing products.<br />- The lowest dose necessary to achieve efficacy should be used.<br />- Not more than 4 doses should be taken in any 24-hour period.</p><p style="margin-left:6.8pt; margin-right:4.65pt"><strong>Adults (including the elderly) and children aged 16 years and over:</strong><br />- One or two tablets up to four times daily as required.</p><p style="margin-left:6.8pt; margin-right:4.65pt"><strong>Children aged 12-15 years:</strong><br />- One tablet up to four times daily as required.<br />- Children should not be given Panadol Actifast for more than 3 days without consulting a doctor.<br />Panadol Actifast is not recommended for children under 12 years of age.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.8pt; margin-right:86.0pt">Events reported from extensive post-marketing experience at therapeutic/labelled dose and considered attributable are mentioned below by System Organ Class and frequency.</p><p style="margin-left:6.8pt; margin-right:86.0pt">Frequencies are defined as: very common (&ge; 1/10), common (&ge;1/100, &lt;1/10), uncommon (&ge; 1/1,000, &lt;1/100), rare (&ge;1/10,000, &lt;1/1000), very rare (&lt;1/10,000), not known (cannot be estimated from available data).</p><p style="margin-left:6.8pt; margin-right:86.0pt">Adverse event frequencies have been estimated from spontaneous reports received through post-marketing data</p><p style="margin-left:6.8pt; margin-right:86.0pt"><strong>Blood and lymphatic system disorders</strong><br />Very rare: Thrombocytopaenia<br /><strong>Immune system disorders</strong><br />Very rare: Anaphylaxis, cutaneous hypersensitivity reactions including, among others, skin rashes, angioedema and Stevens Johnson syndrome and Toxic Epidermal Necrolysis.<br />Very rare cases of serious skin reactions have been reported<br /><strong>Respiratory, thoracic and mediastinal disorders</strong><br />Very rare: bronchospasm in patients sensitive to aspirin and other NSAIDs<br /><strong>Hepatobiliary disorders </strong></p><p style="margin-left:6.8pt; margin-right:86.0pt">Very rare: Hepatic dysfunction</p><p style="margin-left:6.8pt; margin-right:86.0pt">To report any side effect(s):<br />Kingdom of Saudi Arabia<br />-National Pharmacovigilance centre (NPC)<br />Fax: +966-11-205-7662<br />Reporting Hotline: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><p style="margin-left:6.8pt; margin-right:86.0pt">&nbsp;</p><p style="margin-left:6.8pt; margin-right:86.0pt"><strong><u>Overdose</u><br />Paracetamol</strong><br />- Paracetamol overdose may cause liver failure which can lead to liver transplant or death. Acute pancreatitis has been observed, usually with hepatic dysfunction and liver toxicity.<br />- There is a risk of poisoning with paracetamol particularly in elderly subjects, young children, patients with liver disease, cases of chronic alcoholism and in patients with chronic malnutrition. Overdosing may be fatal in these cases.<br />- Symptoms generally appear within the first 24 hours and may comprise: nausea, vomiting, anorexia, pallor, and abdominal pain, or patients may be asymptomatic.<br />- Overdose of paracetamol in a single administration in adults or in children can cause liver cell necrosis likely to induce complete and irreversible necrosis, resulting in hepatocellular insufficiency, metabolic acidosis, and encephalopathy which may lead to coma and death.<br />- Simultaneously, increased levels of hepatic transaminases (AST, ALT), lactate dehydrogenase and bilirubin are observed together with increased prothrombin levels that may appear 12 to 48 hours after administration.<br />- Liver damage is likely in adults who have taken more than the recommended amounts of paracetamol. It is considered that excess quantities of toxic metabolite (usually adequately detoxified by glutathione when normal doses of paracetamol are ingested), become irreversibly bound to liver tissue. Some patients may be at increased risk of liver damage from paracetamol toxicity. Risk factors include: If the patient:<br />- Is on long-term treatment with carbamazepine, phenobarbitone, phenytoin, primidone, rifampicin, St John&rsquo;s Wort or other drugs that induceliver enzymes.<br />- Regularly consumes ethanol in excess of recommended amounts.</p><p style="margin-left:6.8pt; margin-right:86.0pt">- Is likely to be glutathione depleted e.g. eating disorders, cystic fibrosis, HIV infection, starvation, cachexia.</p><p style="margin-left:6.8pt; margin-right:86.0pt">&nbsp;</p><p style="margin-left:6.8pt; margin-right:86.0pt"><strong>Emergency Procedure:</strong><br />- Immediate transfer to hospital.<br />- Blood sampling to determine initial paracetamol plasma concentration. In the case of a single acute overdose, paracetamol plasma concentration should be measured 4 hours post-ingestion.<br />- Administration of activated charcoal should be considered if &gt; 150mg/kg paracetamol has been taken within 1 hour.<br />- The antidote N-acetylcysteine, should be administered as soon as possible in accordance with National treatment guidelines.<br />- Symptomatic treatment should be implemented.<br />- High doses of sodium bicarbonate may be expected to induce gastrointestinal symptoms including belching and nausea. Gastric rupture has rarely been reported. In addition, high doses of sodium bicarbonate may cause hypernatraemia; hyperosmolarity and metabolic alkalosis, particularly in patients with renal disease. Electrolytes should be monitored and if abnormalities occur, the patient should be managed appropriately after seeking expert advice.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:24.2pt; margin-right:4.65pt; text-indent:-17.9pt">&nbsp;</p><p style="margin-left:24.2pt; margin-right:4.65pt; text-indent:-17.9pt">Store below 30&deg; C.</p><p style="margin-left:24.2pt; margin-right:4.65pt; text-indent:-17.9pt">Store in original container.</p><p style="margin-left:24.2pt; margin-right:4.65pt; text-indent:-17.9pt">This product is protected in a sealed blister. Do not use if blister or foil is broken.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:6.8pt; margin-right:26.8pt">Description<br />Each tablet contains: 500 mg paracetamol Ph.<br />Eur Excipients: Contains 176 mg(7.5mmol) sodium per tablet</p><p style="margin-left:6.8pt; margin-right:26.8pt">&nbsp;</p><p style="margin-left:6.8pt; margin-right:26.8pt">Other Ingredients:<br />Tablet core: Sodium bicarbonate, Pregelatinised<br />starch, Povidone, Maize starch, Microcrystalline<br />cellulose, Magnesium stearate, Carnauba wax,<br />Sodium starch glycolate, Collodial anhydrous<br />silica and Purified water.<br />Film coat: Opadry II Y-22-7719 White which<br />contains: Titanium dioxide (E171), Polydextrose,<br />Hypromellose, Triacetin and Macrogols</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Pack size: 20’s ( 10’s Blisters x 2 )
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufactured by: GlaxoSmithKline Dungarvan Ltd, Ireland.<br />MAH: GlaxoSmithKline Consumer Healthcare (Ireland) Limited, Ireland.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Leaflet revised in February 2020.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="margin-left:-.3pt; margin-right:10.35pt; text-align:right; text-indent:-.4pt">بنادول أكتيفاست عبارة عن مسكن وخافض للحرار ة. يوصى به للعلاج قصير الأجل للآلام الخفيفة مثل الصداع وآلام العضلات والعظام وآلام الحيض وآلام الأسنان ولتخفيف&nbsp;أعرا ض الحمى&nbsp;وآلام ونزلات البرد والإنفلونزا</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:1.2pt; text-align:justify; text-indent:-.5pt"><strong>أ. لا تتناول بنادول أكتيفاست في حالة:</strong><br />- وجود فرط حساسية تجاه الباراسيتامول أو أي من&nbsp;مواد السواغ الأخرى حالياَ&nbsp;أو سابقاَ.<br /><strong>ب. تناول بنادول أكتيفاست بحذر:</strong><br />- يحتوي هذا المنتج عل ى الباراسيتامول. لا يُستخدم مع أي منتجات&nbsp;أخرى تحتوي على الباراسيتامول. إذ قد يؤدي&nbsp;الاستخدام المتزامن مع منتجات أخرى تحتوي على<br />الباراسيتامول إلى تشكيل جرعة زائدة.قد تتسبب جرعة الباراسيتامول الزائدة في فشل كبدي والذ ي قد&nbsp;يؤدي إللى&nbsp;زرع كبد أو إلى&nbsp;الوفاة.<br />- تم تسجيل حالات من الخلل&nbsp;الوظيفي/الفشل الكبدي بين مرضى&nbsp;مصابين باستنزاف مستويات الجلوتاثيون، مثل الذين&nbsp;يعانون من سوء تغذية حاد أو فقدان للشهية&nbsp;أو انخفاض في مؤشر&nbsp;كتلة الجسم&nbsp;أو مستخدمي الكحوليات بكثافة.<br />- يجب توخي الحذ ر مع المرضى الذين يعانون من حالات&nbsp;نفاد الجلوتاثيون مثل الإنتان؛ فقد يُزيد استخدام الباراسيتامول&nbsp;من خطر الحماض الأيضي.<br />- يحتوي هذا المنتج الدوائ ي عل ى ٣٥٢ ملجم&nbsp;من الصوديوم&nbsp;في كل جرعة ، أي ما يعادل ١٧,٦ % من الحد الأقصى&nbsp;اليومي&nbsp;من الصوديوم المُوصى&nbsp;به من&nbsp;منظمة الصحة&nbsp;العالمية. أقصى&nbsp;جرعة&nbsp;يومية من هذا المنتج تعادل ٧٠,٤ % من الحد&nbsp;الأقصى&nbsp;اليومي من الصوديوم المُوصى&nbsp;به من منظمة الصحة العالمية. يُعتبر بنادول أكتيفاست غنياً&nbsp;بالصوديوم. يجب وضع ذلك في&nbsp;الاعتبار بشكل خاص بالنسبة لمَن يتبع نظاماَ&nbsp;غذائياَ&nbsp;قليل الملح.<br />- وجود مرض كبدي كامن يزيد من&nbsp;خطورة حدوث تلف كبدي&nbsp;متعلق بالباراسيتامول.<br />يجب على المرضى الذي ن تم تشخيص إصابتهم بضعف في&nbsp;الكبد أو الكلى طلب&nbsp;المشورة الطبية قبل&nbsp;تناول هذ ا الدوا ء.<br />- إذ ا لم&nbsp;تختف الأعراض، فاطلب المشورة الطبية. قد&nbsp;يضرك الاستخدام لفترات طويلة إلا إذا كان تحت إشراف طبي.<br />- يُحفظ بعيداا عن مرأى ومتناول الأطفال.</p><p dir="RTL" style="margin-left:0in; margin-right:1.2pt; text-align:justify; text-indent:-.5pt"><strong>ج. تناوُل أدوية&nbsp;أخرى:</strong><br />قد تزداد سرعة امتصاص الباراسيتامول بواسطة&nbsp;الميتوكلوبراميد أو الدومبيريدون، ويقل الامتصاص عند تناول الكولسترامين. قد&nbsp;يزداد التأثير المضاد للتخثر للوارفارين&nbsp;ومركبات الكومارين الأخرى عند الاستخدام<br />اليومي المطول للباراسيتامول مع زيادة خطر النزيف؛ بينما&nbsp;الجرعات العرضية&nbsp;ليس لها تأثير كبير.</p><p dir="RTL" style="margin-left:0in; margin-right:1.2pt; text-align:justify; text-indent:-.5pt"><strong>د. الحمل والرضاعة الطبيعية:</strong><br />- تشير كمية كبيرة من البيانات المتعلقة بالمرأة الحامل&nbsp;إلى عدم حدوث تشوهات ولا تسمم للجنين/المولود. أظهرت الدراسات الوبائية على&nbsp;النمو العصبي لدى الأطفال&nbsp;المعرضين للباراسيتامول داخل الرحم نتائج غير قاطعة.<br />يمكن استخدام الباراسيتامول في&nbsp;أثناء الحمل إذا لزم الأمر من&nbsp;الناحية السريرية ؛ إلا أنه يجب استخدامه بأقل&nbsp;جرعة فعالة&nbsp;-لأقصر فترة ممكنة وبأقل معدل تكرار ممكن.<br />- يُفرز الباراسيتامول في لبن الأم. ومع ذلك، لا يُعتبر مستوى&nbsp;الباراسيتامول الموجود ضارَا. لا تُفيد البيانات المنشورة المتاحة بمنع الرضاعة&nbsp;الطبيعية في أثناء استعمال الدواء.</p><p dir="RTL" style="margin-left:0in; margin-right:1.2pt; text-align:justify; text-indent:-.5pt"><strong>ه. القدرة على أداء المھام التي تتطلب مهارة الحكم على الأشياء أ و مهارات حركية أو معرفية:</strong><br />- لا يوجد تأثير كبير على القدرة على القيادة واستخدا م الآلات.</p><p dir="RTL" style="margin-left:0in; margin-right:1.2pt; text-align:justify; text-indent:-.5pt">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">- للتناول عن طريق الفم فقط.<br />- لا تتجاوز الجرعة المحددة.<br />- لا يُستخدم مع المنتجات الأخرى التي تحتوي على&nbsp;الباراسيتامول<br />- يجب تناول أقل&nbsp;جرعة ضرورية ليكون الدواء فعالاَ.<br />- يجب عدم تناول أكثر من ٤ جرعات كل ٢٤ ساعة.</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt"><strong>البالغون (بما في ذلك كبار السن) والأطفال البالغة أعمارهم&nbsp;١٦ عامًا فما فوق:</strong><br />- قرص أو قرصان حتى أربع&nbsp;مرات يومياً&nbsp;حسب الحاجة.</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">&nbsp;</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt"><strong>الأطفال من ١٢ إلى ١٥ عامًا:</strong><br />- قرص واحد حتى&nbsp;أربع مرات يومياً&nbsp;حسب الحاجة.<br />- يجب عدم إعطاء الأطفال بنادول أكتيفاست لأكثر من ٣ أيام&nbsp;دون استشارة الطبيب.<br />يُوصى بعدم إعطاء بنادول أكتيفاست للأطفال الذين تقل&nbsp;أعمارهم عن ١٢ عاماَ.</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt"><strong>الآثار الجانبية المحتملة</strong><br />الحالات التي تم&nbsp;الإبلاغ عنها من خلال تجربة ما بعد التسويق&nbsp;الشاملة بحسب الجرعة العلاجية/الموصوفة والتي يمكن&nbsp;أخذها بالإعتبار؛ مذكوره أدناه و مُرتّبة حسب فئة الجهاز&nbsp;العضوي ومعدل التكرار.</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">وتُحدد معدّلات التكرار كما يلي: شائعة جدًا (&le; ١٠/١)، وﺷﺎﺋﻌﺔ (&le; ١٠٠/١ و&lt; ١ / ١٠)&nbsp;وغير&nbsp;وﺷﺎﺋﻌﺔ (&le; ١٠٠٠/١ و&lt; ١ / ١٠٠) و&nbsp;ﻧﺎدرة (&le; &nbsp;١٠٠٠٠/١ و&lt; ١ / ١٠٠٠)&nbsp;&nbsp;وﻧﺎدرة ﺟﺪًا (&lt; ١ / ١٠٠٠٠)&nbsp;وغير&nbsp;ﻣﻌﺮوﻓﺔ (ﻻ يمكن&nbsp;ﺗﻘﺪيرها&nbsp;ﻣﻦ اﻟﺒياﻧﺎت اﻟﻤﺘﻮﻓﺮة).&nbsp;</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt"><strong>اضطرابات الدم والجهاز اللمفاوي</strong><br />نادرة جدا: نقص الصفائح الدموية<br /><strong>اضطرابات الجهاز المناعي</strong><br />نادرة جدا: الحساسية المفرطة، وتفاعلات فرط الحساسية<br />الجلدية بما في ذلك، على&nbsp;سبيل المثال، الطفح الجلدي،<br />والوذمة الوعائية، ومتلازمة ستيفنز جونسون، وتقشر&nbsp;الأنسجة المتموتة البشروية التسممي.<br />تم الإبلاغ عن حالات نادرة جدا من التفاعلات الجلدية الخطيرة</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt"><strong>اضطرابات الجھاز التنفسي والصدر والضطرابات المنصفية</strong><br />نادرة جدا: تشنج قصبي بين المرضى الذين يعانون من<br />حساسية من الأسبرين والأدوية المضادة للالتهاب&nbsp;اللاستيرويدية الأخرى.<br /><strong>العتلالت الكبدية الصفراوية</strong><br />نادرة جدا: خلل في وظائف الكبد</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">للإبلاغ عن أي آثار جانبية:<br />المملكة العربية السعودية</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">&nbsp;- المركز الوطني للتيقظ والسلامة الدوائية (NPC)<br />الاتصال بالرقم الموحد: 19999<br />npc.drug@sfda.gov.sa : البريد الإلكتروني<br />https://ade.sfda.gov.sa : الموقع الإلكتروني</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">&nbsp;</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">الجرعة الزائدة<br />الباراسيتامول:<br />- قد تتسبب جرعة الباراسيتامول الزائدة في فشل كبدي والذي&nbsp;قد يؤدي إلى&nbsp;زرع كبد أو إلى&nbsp;الوفاة. لوحظت الإصابة&nbsp;بالتهاب&nbsp;البنكرياس الحاد، عادة مع اختلال في وظائف الكبد وتسمم&nbsp;الكبد.<br />- هناك خطر بحدوث تسمم بالباراسيتامول خاصة بين&nbsp;المرضى كبار السن&nbsp;والأطفال الصغار والمرضى&nbsp;الذين&nbsp;<br />يعانون من أمراض الكبد وحالات إدمان الكحول المزمن<br />وبين المرضى الذين&nbsp;يعانون من سوء التغذية المزمن. قد&nbsp;تكون الجرعة&nbsp;الزائدة قاتلة في هذه الحالات.<br />- الأعرا ض التي تظهر عامة خلال أول ٢٤ ساعة وقد&nbsp;تشمل:&nbsp;الغثيان، والتقيؤ، وفقدان الشهية، والشحوب، وآلام البطن، أو&nbsp;قد لا يعاني المريض من&nbsp;أعراض.<br />- قد&nbsp;تتسبب الجرعة الزائدة من الباراسيتامول في المرة&nbsp;الواحدة للبالغين أو الأطفال في&nbsp;نخر لخلايا الكبد قد يتفاقم إلى&nbsp;نخر كامل غير قابل&nbsp;للعلاج، مما ينجم عنه&nbsp;قصور خلايا الكبد&nbsp;والحماض الأيضي واعتلال الدماغ الذي قد&nbsp;يؤدي إلى&nbsp;الغيبوبة والوفاة.<br />في نفس الوقت، لوحظت زيادة مستويات ناقلات أمين الكبد&nbsp;اللاكتات الغير مهدرج، والبيليروبين مع زيادة ،(AST ،ALT)،&nbsp;مستويات البروثرومبين التي قد&nbsp;تظهر بعد ١٢ إل ى ٤٨ ساعة&nbsp;من تناول الدوا ء.<br />- من المحتمل حدوث تلف للكبد لدى البالغين الذين&nbsp;تناولوا&nbsp;أكثر من الكميات الموصى بها من الباراسيتامول.<br />هناك افتراض بأن الكميات الزائدة من المستقلبات السامة (عادة ما تُزال السموم منها بشكل كاف من خلا ل الجلوتاثيون<br />عند تناول جرعات طبيعية من الباراسيتامول) تترابط مع&nbsp;أنسجة الكبد بشكل غير قاب ل للعلاج.<br />قد يكون بعض المرضى أكثر عرضة لخطر تل ف الكبد نتيجة&nbsp;سمية الباراسيتامول. أمثلة عوامل الخطر: إذ ا كان المريض:<br />- يتلقى علاجاَ على&nbsp;المدى&nbsp;الطويل باستخدام الكاربامازيبين، أو الفينوباربيتون، أو الفينيتوين، أو البريميدون، أو</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">الريفامبيسين، أو نبتة العرن المثقوب، أو غير ذلك من&nbsp;الأدوية&nbsp;التي تحفز&nbsp; إنزيمات الكبد.<br />- يستخدم الإيثانول بانتظام بما يزيد ع ن الكميات الموصى بها.<br />- من المحتمل أن يُصاب باستنفاد الجلوتاثيون، على سبيل&nbsp;المثال اضطرابات تناول الطعام، والتليف الكيسي، وعدوى&nbsp;فيروس نقص المناعة البشري، والمخمصة، والهزال.</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt"><strong>إجراءات الطوارئ:</strong><br />- النقل الفوري إلى المستشفى.<br />- أخذ&nbsp;عينات من الدم لتحديد تركيز الباراسيتامول الأولي في&nbsp;البلازما. عند&nbsp;تناول جرعة زائدة&nbsp;جدا&nbsp;واحدة ، ينبغي قياس&nbsp;تركيز بلازما الباراسيتامول بعد ٤ ساعات من&nbsp;تناول الدواء.<br />- ينبغي التفكير في تناول الفحم المنشط عند تناول أكثر من&nbsp;١٥٠ ملجم/كجم من الباراسيتامول خلال ساعة&nbsp;واحدة.<br />- يجب إعطاء الترياق أسيتيل سيستين في أسرع وقت ممكن&nbsp;وفقاَ للمبادئ التوجيهية العلاجية الوطنية.<br />- يجب بدء علاج الأعراض.<br />- من المتوقع أن تتسبب الجرعات العالية من بيكربونات&nbsp;الصوديوم في&nbsp;ظهور أعراض معدية معوية، بما في ذلك&nbsp;التجشؤ والغثيان. من النادر الإبلاغ عن&nbsp;حدوث فتق بالمعدة.<br />بالإضافة إلى ذلك، قد تتسبب الجرعات العالية&nbsp;من بيكربونات&nbsp;الصوديوم ف ي الإصابة&nbsp;بارتفاع الصوديوم في الدم؛ وفرط&nbsp;الأسمولية والقلاء الاستقلابي، خاصة لدى المرضى&nbsp;الذين&nbsp;يعانون من مرض كلوي. ينبغي مراقبة الشوارد الكهربائية؛<br />وإذا حدث خلل ، يجب إدارة حالة المريض بشكل مناسب بعد&nbsp;طلب المشورة الطبية المتخصصة.</p><p dir="RTL" style="margin-left:0in; margin-right:-.15pt; text-align:right; text-indent:-.5pt">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="margin-left:0in; margin-right:1.2pt; text-align:right; text-indent:-.5pt">يُخزن في&nbsp;درجة حرار ة أقل من&nbsp;٣٠ درجة مئوية.<br />يُحفظ في العلبة&nbsp;الأصلية.<br />هذا المنتج يحميه شريط فقاعي مغلق. لا تستخدمه إذا كان أي من الشريط الفقاعي أو الغلاف الفويل مكسوارا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>الوصف<br />يحتوي كل قرص على: ٥٠٠ ملج م من الباراسيتامول(دستور<br />الأدوية الأوربي)<br />مواد السواغ: يحتوي كل قر ص على ١٧٦ ملج م ( ٧,٥ مليمول) من الصوديوم.</p><p>&nbsp;</p><p>مكوّنات أخرى:<br />لب القرص: بيكربونات صوديوم، ونشاء معدل، وبوفيدون،<br />ونشاء ذرة، وسليلوز دقيق التبلور، وستيرات مغنسيوم،<br />وشمع كرنوبا، وجلايكولات نشاء الصوديوم، وسيليكا<br />غروانية لامائية، وماء مقطر.</p><p>غلاف القرص:<br />أبيض من نوع&nbsp; Opadry II Y-22-&nbsp; 7719 ويحتوي على&nbsp;ثاني أكسيد التيتانيوم ( 171 E) وبولي ديكستروز،&nbsp;وهايبروميلوز، وثلاثي الأسيتين، وماكروجول.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>حجم العبوة : ٢٠ قرص&nbsp;( ٢ شريط &times;١٠ قرص )</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>صنع من قبل: جلاكسوسيميثكلاين، دانجارفان المحدودة.أيرلندا.</p><p>الشركة المالكة لحق التسويق: جلاكسو سيميثكلاين كونسيومر هيلث كير (أيرلندا) المحدودة ، أيرلندا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة النشرة في فبراير  2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Panadol Actifast Tablets 500mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains paracetamol 500mg.
Excipients: Contains 173mg (7.Smmol) sodium per tablet. For a full list. of   excipients,,see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablet
White to off-white film-coated capsule shaped tablets with flat edges, debossed with the letter 'P' on one side and '--' on the
other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:12.35pt; margin-right:54.7pt; text-indent:.95pt">A mild analgesic and antipyretic recommended in the short-term management of the symptoms of headaches, musculoskeletal disorders, menstrual pains, toothache and for relieving fever, aches and pains of common colds and flu.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:13.05pt; margin-right:0in">For oral administration.</p><p style="margin-left:13.05pt; margin-right:0in"><br />Adults (including the elderly) and children aged 16 years and over:<br />One or two tablets up to four times daily as required.</p><p style="margin-left:13.05pt; margin-right:0in"><br />Children aged 12-15 years:<br />One tablet up to four times daily as required.<br />Children should not be given Panadol ActiFast for more than 3 days without consulting a doctor.</p><p style="margin-left:13.05pt; margin-right:0in"><br />Not recommended for children under 12 years of age.</p><p style="margin-left:13.05pt; margin-right:0in"><br />Minimum dosing interval: 4 hours.<br />Not more than 4 doses should be taken in any 24-hour period.<br />Do not exceed the stated dose.<br />Should not be used with other paracetamol containing products.<br />The lowest dose necessary to achieve efficacy should be used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Panadol Actifast is contraindicated in patients with a previous history of hypersensitivity to paracetamol or any of the other
ingredients.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:12.65pt; margin-right:37.45pt; text-indent:-.65pt">Contains paracetamol. Do not use with any other paracetamol-containing products. The concomitant use with other products<br />containing paracetamol may lead to an overdose. Paracetamol overdose may cause liver failure which can lead to liver<br />transplant or death.<br />Cases of hepatic dysfunction/failure have been reported in patients with depleted glutathione levels, such as those who are<br />severely malnourished, anorexic, have a low body mass index or are chronic heavy users of alcohol.<br />Caution in patients with glutathione depleted states such as sepsis; the use of paracetamol may increase the risk of metabolic<br />acidosis.</p><p style="margin-left:12.65pt; margin-right:37.45pt; text-indent:-.65pt">This medicinal product contains 352 mg of sodium per dose, equivalent to 17.6% of the WHO recommended maximum daily<br />intake for sodium. The maximum daily dose of this product is equivalent to 70.4% of the WHO recommended maximum daily<br />intake for sodium. Panadol ActiFast is considered high in sodium. This should be particularly taken into account for those on a<br />low salt diet.<br />Underlying liver disease increases the risk of paracetamol related liver damage. Patients who have been diagnosed with liver or<br />kidney impairment must seek medical advice before taking this medication.<br />If symptoms persist, seek medical advice. Prolonged use except under medical supervision may be harmful. Keep out of the<br />sight and reach of children.</p><p style="margin-left:12.65pt; margin-right:37.45pt; text-indent:-.65pt">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:28.4pt; margin-right:16.2pt; text-indent:-.1pt">The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by<br />cholestyramine. The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of<br />paracetamol with increased risk of bleeding; occasional doses have no significant effect.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:28.65pt; text-indent:-.25pt">Pregnancy<br />A large amount of data on pregnant women indicate neither malformative, nor feto/neonatal toxicity. Epidemiological studies<br />on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically needed, paracetamol<br />can be used during pregnancy however it should be used at the lowest effective dose for the shortest possible time and at the<br />lowest possible frequency.</p><p style="margin-left:28.65pt; text-indent:-.25pt"><br />Lactation<br />Paracetamol is excreted in breast milk. However, the level of paracetamol present is not considered to be harmful. Available<br />published data do not contraindicate breastfeeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:27.75pt">No significant effect</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:28.75pt; text-indent:-.1pt">Events reported from extensive post-marketing experience at therapeutic / labelled dose ai1d considered attributable are tabulated below by System Organ Class and frequency .</p><p style="margin-left:28.15pt; margin-right:25.05pt">Frequencies are defined as: very common (&#39;.2=1 &nbsp;/ 10),&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; common (2:1/100, &lt; l/1 0), uncommon (2:1/1,000 &nbsp;&lt;1/l &nbsp;00 ), rare (2! 1/10,000, &lt;1/1000}, very rare (&lt;1/10 , 000), not known (cannot be estimated from available data}.</p><p style="margin-left:28.05pt; margin-right:0in">Adverse event frequencies have been estimated from spontaneous reports received through post marketing data.</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="border-color:black; height:12.7pt; vertical-align:top; width:130.3pt"><p style="margin-left:6.05pt"><strong>Body </strong><strong>System</strong></p></td><td style="border-color:black; height:12.7pt; vertical-align:top; width:168.75pt"><p style="margin-left:5.7pt; margin-right:0in"><strong>Undesirable Effect</strong></p></td><td style="border-color:black; height:12.7pt; vertical-align:top; width:70.9pt"><p style="margin-left:5.95pt; margin-right:0in"><strong>Frequency</strong></p></td></tr><tr><td colspan="3" style="border-color:black; height:12.45pt; vertical-align:top; width:369.95pt"><p style="margin-left:5.95pt"><strong>Paracetamol</strong></p></td></tr><tr><td style="border-color:black; height:47.05pt; vertical-align:top; width:130.3pt"><p style="margin-left:5.7pt; margin-right:34.45pt; text-indent:.3pt">Blood and lymphatic system disorders</p></td><td style="height:47.05pt; vertical-align:top; width:168.75pt"><p style="margin-left:5.4pt">Thrombocytopaenia</p></td><td style="height:47.05pt; vertical-align:top; width:70.9pt"><p style="margin-left:6.1pt">Very rare</p></td></tr><tr><td style="border-color:black; height:58.35pt; vertical-align:top; width:130.3pt"><p style="margin-left:5.95pt">Immune System disorders</p></td><td style="height:58.35pt; vertical-align:top; width:168.75pt"><p>Anaphylaxis<br />Cutaneous hypersensitivity reactions, including, among others,<br />skin rashes, angioedema and Stevens Johnson syndrome and<br />Toxic Epidermal Necrolysis.<br />Very rare cases of serious skin reactions have been reported</p></td><td style="height:58.35pt; vertical-align:top; width:70.9pt"><p style="margin-left:5.6pt">Very rare</p></td></tr><tr><td style="border-color:black; height:53.35pt; vertical-align:top; width:130.3pt"><p style="margin-left:5.9pt; margin-right:16.4pt; text-indent:.4pt">Respiratory, thoracic and mediastinal disorders</p></td><td style="height:53.35pt; vertical-align:top; width:168.75pt"><p style="margin-left:5.85pt; margin-right:7.45pt; text-indent:-.35pt">Bronchospasm in patients sensitive to aspirin and other NSAIDs</p></td><td style="height:53.35pt; vertical-align:top; width:70.9pt"><p style="margin-left:6.1pt; margin-right:0in">Very rare</p></td></tr><tr><td style="border-color:black; height:26.85pt; vertical-align:top; width:130.3pt"><p style="margin-left:6.05pt; margin-right:0in">Hepatobiljary disorders</p></td><td style="height:26.85pt; vertical-align:top; width:168.75pt"><p style="margin-left:5.55pt; margin-right:0in">Hepatic dysfunction</p></td><td style="height:26.85pt; vertical-align:top; width:70.9pt"><p>Very rare</p></td></tr></tbody></table><p>Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued<br />monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected<br />adverse reactions via HPRA Pharmacovigilance website: www.hpra.ie.</p><p>To report any side effect(s):<br />Kingdom of Saudi Arabia<br />-National Pharmacovigilance centre (NPC)<br />Fax: +966-11-205-7662<br />Reporting Hotline: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:28.6pt; margin-right:16.2pt; text-indent:.45pt">Paracetamol overdose may cause liver failure which can lead to liver transplant or death. Acute pancreatitis has been observed,<br />usually with hepatic dysfunction and liver toxicity.<br />There is a risk of poisoning with paracetamol particularly in elderly subjects, young children, patients with liver disease, cases of<br />chronic alcoholism and in patients with chronic malnutrition. Overdosing may be fatal in these cases.<br />Symptoms generally appear within the first 24 hours and may comprise: nausea, vomiting, anorexia, pallor, and abdominal pain,<br />or patients may be asymptomatic.<br />Overdose of paracetamol in a single administration in adults or in children can cause liver cell necrosis likely to induce<br />complete and irreversible necrosis, resulting in hepatocellular insufficiency, metabolic acidosis and encephalopathy which may<br />lead to coma and death.<br />Simultaneously, increased levels of hepatic transaminases (AST, ALT), lactate dehydrogenase and bilirubin are observed<br />together with increased prothrombin levels that may appear 12 to 48 hours after administration.<br />Liver damage is likely in adults who have taken more than the recommended amounts of paracetamol. It is considered that<br />excess quantities of toxic metabolite (usually adequately detoxified by glutathione when normal doses of paracetamol are<br />ingested), become irreversibly bound to liver tissue.<br />Some patients may be at increased risk of liver damage from paracetamol toxicity.<br />Risk Factors include: If the patient;</p><ul><li style="margin-left: 28.6pt; margin-right: 16.2pt; text-indent: 0.45pt;">&nbsp;Is on long-term treatment with carbamazepine, phenobarbitone, phenytoin, primidone, rifampicin, St John&rsquo;s Wort</li></ul><p style="margin-left:28.6pt; margin-right:16.2pt; text-indent:.45pt">or other drugs that induce liver enzymes.</p><ul><li style="margin-left: 28.6pt; margin-right: 16.2pt; text-indent: 0.45pt;">&nbsp;Regularly consumes ethanol in excess of recommended amounts.</li><li style="margin-left: 28.6pt; margin-right: 16.2pt; text-indent: 0.45pt;">&nbsp;Is likely to be glutathione depleted e.g. eating disorders, cystic fibrosis, HIV infection, starvation, cachexia</li></ul><p style="margin-left:28.6pt; margin-right:16.2pt; text-indent:0.45pt">&nbsp;</p><p style="margin-left:28.6pt; margin-right:16.2pt; text-indent:0.45pt"><u>Emergency Procedure:</u><br />Immediate transfer to hospital.<br />Blood sampling to determine initial paracetamol plasma concentration. In the case of a single acute overdose, paracetamol<br />plasma concentration should be measured 4 hours post ingestion.<br />Administration of activated charcoal should be considered if &gt;150mg/kg paracetamol has been taken within 1 hour.<br />The antidote N-acetylcysteine, should be administered as soon as possible in accordance with National treatment guidelines.<br />Symptomatic treatment should be implemented.<br />High doses of sodium bicarbonate may be expected to induce gastrointestinal symptoms including belching and nausea.<br />Gastric rupture has rarely been reported. In addition, high doses of sodium bicarbonate may cause hypernatraemia;<br />hyperosmolarity and metabolic alkalosis, particularly in patients with renal disease. Electrolytes should be monitored and if<br />abnormalities occur, the patient should be managed appropriately after seeking expert advice</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:28.1pt; margin-right:16.2pt; text-indent:.55pt">Paracetamol is an analgesic and antipyretic. Its mechanism of action is believed to include inhibition of prostaglandin synthesis, primarily within the central 11ervous system. The lack of peripheral prostaglandin inhibition confers important pharmacological properties such as the maintenance of the protective prostaglandins within the gastrointestinal tract Paracetamol is, therefore, particularly suitable fr)r patients with a history of disease or on concomitant medicaion where peripheral prostaglandin inhibition would be undesirable (such as, for example, those with a history of GI bleeding or the elderly).</p><p>&nbsp;</p><p style="margin-left:27.95pt; margin-right:0in">Sodium bicarbonate has no known analgesic activity.</p><p>&nbsp;</p><p style="margin-left:27.75pt; margin-right:24.3pt; text-indent:-.05pt">Clinical data showed PANADOL Actifast to provide faster onset of analgesia than standard paracetamol tablets. Onset of pain relief for PANADOL Actifast showed no difference in both fasted and fed states in an acute pain study.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:27.75pt; margin-right:22.8pt; text-indent:1.15pt">Paracetamol is metabolised in the liver and excreted in the urine mainly as glucuronide and sulphate conjugates&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; less than 5 % is excreted as unmodified paracetamol. Binding to the plasma proteins is minimal at therapeutic concentrations.</p><p>&nbsp;</p><p style="margin-left:28.1pt; margin-right:16.2pt; text-indent:-.15pt">Sodium bicarbonate speeds up tablet dissolution in the stomach and enhances gastric emptying of paracetamol into the small intestine where it is absorbed.</p><p style="margin-left:25.3pt; margin-right:25.05pt; text-indent:-.15pt">In human volunteer phannacokinetic studies, mean maximum plasma concentrations were reached at leasttwice as for PANADOL Actifast tablets compared to standard paracetamol tablets at both a one and two tablet dose and these were statistically significant.</p><p>&nbsp;</p><p style="margin-left:25.25pt; margin-right:16.2pt; text-indent:-.1pt">The extent of absorption for PANADOL Actifast tablets is equivalent to that for standard paracetamol tablets as shown by AUC at both a one and two tablet dose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:25.1pt; margin-right:25.4pt; text-align:justify; text-indent:-.05pt">Conventional studies using the currently accepted standards for the evaluation of toxicity to reproduction and development<br />are not available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:24.45pt">Tablet core:<br />Sodium hydrogen carbonate Pregelatinised starch Povidone<br />Maize starch Microcrystalline cellulose Magnesium stearate Carnauba wax<br />Sodium starch glycolate Colloidal anhydrous silica<br />The tablets are coated with Opadry II Y-22-7719 White which contains: Titanium dioxide (E171)<br />Polydextrose Hypromellose Triacetin Macrogol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:23.9pt; margin-right:0in">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:24.15pt">Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:.25pt; margin-right:-.3pt; text-indent:-.25pt">Opaque PVD/Aluminium foil blister strips packed into cardboard cartons containing 4, 6, 8, 10, 12, 16, 20, 24 or 32 tablets or<br />into cardboard wallets containing 10 or 12 tablets.</p><p style="margin-left:.25pt; margin-right:-.3pt; text-indent:-.25pt"><br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:25.1pt">No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                GlaxoSmithKline Consumer Healthcare (Ireland) Limited
12 Riverwalk
Citywest Business Campus
Dublin 24
Ireland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>